231 related articles for article (PubMed ID: 35898688)
21. Cockayne syndrome and xeroderma pigmentosum.
Rapin I; Lindenbaum Y; Dickson DW; Kraemer KH; Robbins JH
Neurology; 2000 Nov; 55(10):1442-9. PubMed ID: 11185579
[TBL] [Abstract][Full Text] [Related]
22. Mouse model for the DNA repair/basal transcription disorder trichothiodystrophy reveals cancer predisposition.
de Boer J; van Steeg H; Berg RJ; Garssen J; de Wit J; van Oostrum CT; Beems RB; van der Horst GT; van Kreijl CF; de Gruijl FR; Bootsma D; Hoeijmakers JH; Weeda G
Cancer Res; 1999 Jul; 59(14):3489-94. PubMed ID: 10416615
[TBL] [Abstract][Full Text] [Related]
23. [Xeroderma pigmentosum (XP) : A genetic disease sheds light on UV-induced skin cancer].
Emmert B; Hallier E; Schön MP; Emmert S
Hautarzt; 2011 Feb; 62(2):91-7. PubMed ID: 21243329
[TBL] [Abstract][Full Text] [Related]
24. Understanding Xeroderma Pigmentosum Complementation Groups Using Gene Expression Profiling after UV-Light Exposure.
Bowden NA; Beveridge NJ; Ashton KA; Baines KJ; Scott RJ
Int J Mol Sci; 2015 Jul; 16(7):15985-96. PubMed ID: 26184184
[TBL] [Abstract][Full Text] [Related]
25. Ultraviolet damage, DNA repair and vitamin D in nonmelanoma skin cancer and in malignant melanoma: an update.
Reichrath J; Rass K
Adv Exp Med Biol; 2014; 810():208-33. PubMed ID: 25207368
[TBL] [Abstract][Full Text] [Related]
26. Xeroderma pigmentosum--bridging a gap between clinic and laboratory.
Moriwaki S; Kraemer KH
Photodermatol Photoimmunol Photomed; 2001 Apr; 17(2):47-54. PubMed ID: 11338401
[TBL] [Abstract][Full Text] [Related]
27. Xeroderma pigmentosum genes and melanoma risk.
Paszkowska-Szczur K; Scott RJ; Serrano-Fernandez P; Mirecka A; Gapska P; Górski B; Cybulski C; Maleszka R; Sulikowski M; Nagay L; Lubinski J; Dębniak T
Int J Cancer; 2013 Sep; 133(5):1094-100. PubMed ID: 23436679
[TBL] [Abstract][Full Text] [Related]
28. Skin cancer and chromosomal aberrations induced by ultraviolet radiation. Evidence for lack of correlation in xeroderma pigmentosum variant and group E patients.
Seguin LR; Ganges MB; Tarone RE; Robbins JH
Cancer Genet Cytogenet; 1992 Jun; 60(2):111-6. PubMed ID: 1606553
[TBL] [Abstract][Full Text] [Related]
29. Development of effective skin cancer treatment and prevention in xeroderma pigmentosum.
Lambert WC; Lambert MW
Photochem Photobiol; 2015; 91(2):475-83. PubMed ID: 25382223
[TBL] [Abstract][Full Text] [Related]
30. DNA damage and gene therapy of xeroderma pigmentosum, a human DNA repair-deficient disease.
Dupuy A; Sarasin A
Mutat Res; 2015 Jun; 776():2-8. PubMed ID: 26255934
[TBL] [Abstract][Full Text] [Related]
31. Xeroderma pigmentosum clinical practice guidelines.
Moriwaki S; Kanda F; Hayashi M; Yamashita D; Sakai Y; Nishigori C;
J Dermatol; 2017 Oct; 44(10):1087-1096. PubMed ID: 28771907
[TBL] [Abstract][Full Text] [Related]
32. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum.
Pawsey SA; Magnus IA; Ramsay CA; Benson PF; Giannelli F
Q J Med; 1979 Apr; 48(190):179-210. PubMed ID: 504548
[TBL] [Abstract][Full Text] [Related]
33. Phenotypic heterogeneity in the XPB DNA helicase gene (ERCC3): xeroderma pigmentosum without and with Cockayne syndrome.
Oh KS; Khan SG; Jaspers NG; Raams A; Ueda T; Lehmann A; Friedmann PS; Emmert S; Gratchev A; Lachlan K; Lucassan A; Baker CC; Kraemer KH
Hum Mutat; 2006 Nov; 27(11):1092-103. PubMed ID: 16947863
[TBL] [Abstract][Full Text] [Related]
34. Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum.
Spatz A; Giglia-Mari G; Benhamou S; Sarasin A
Cancer Res; 2001 Mar; 61(6):2480-6. PubMed ID: 11289118
[TBL] [Abstract][Full Text] [Related]
35. Xeroderma Pigmentosum: Gene Variants and Splice Variants.
Martens MC; Emmert S; Boeckmann L
Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440347
[TBL] [Abstract][Full Text] [Related]
36. XPC beyond nucleotide excision repair and skin cancers.
Zebian A; Shaito A; Mazurier F; Rezvani HR; Zibara K
Mutat Res Rev Mutat Res; 2019; 782():108286. PubMed ID: 31843141
[TBL] [Abstract][Full Text] [Related]
37. Synergistic interactions between XPC and p53 mutations in double-mutant mice: neural tube abnormalities and accelerated UV radiation-induced skin cancer.
Cheo DL; Meira LB; Hammer RE; Burns DK; Doughty AT; Friedberg EC
Curr Biol; 1996 Dec; 6(12):1691-4. PubMed ID: 8994835
[TBL] [Abstract][Full Text] [Related]
38. [Xeroderma pigmentosum].
Takeuchi S
Nihon Rinsho; 2000 Jul; 58(7):1496-500. PubMed ID: 10921330
[TBL] [Abstract][Full Text] [Related]
39. Correlation of phenotype/genotype in a cohort of 23 xeroderma pigmentosum-variant patients reveals 12 new disease-causing POLH mutations.
Opletalova K; Bourillon A; Yang W; Pouvelle C; Armier J; Despras E; Ludovic M; Mateus C; Robert C; Kannouche P; Soufir N; Sarasin A
Hum Mutat; 2014 Jan; 35(1):117-28. PubMed ID: 24130121
[TBL] [Abstract][Full Text] [Related]
40. High incidence of ultraviolet-B-or chemical-carcinogen-induced skin tumours in mice lacking the xeroderma pigmentosum group A gene.
Nakane H; Takeuchi S; Yuba S; Saijo M; Nakatsu Y; Murai H; Nakatsuru Y; Ishikawa T; Hirota S; Kitamura Y
Nature; 1995 Sep; 377(6545):165-8. PubMed ID: 7675085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
